Categories
Archives
Receive Email Updates
-
-
Certified Licensing Professionals, Inc., 2021 Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
- About Me
Warren D. Woessner Pages
Archives
Tag Archives: Supreme Court
Patents4Life is Four Years Old
On March 24th, Patents4Life forgot to celebrate its 4th anniversary. On March 24, 2009, I started the blog (or is it “blawg”) by posting three articles on fairly recent Fed. Cir. decisions. One of the articles discussed the application of … Continue reading
Posted in Miscellaneous
Tagged Bilski, Classen, Federal Circuit, Patent Law, Supreme Court, Warren Woessner
1 Comment
Supreme Court Hears “Replicant Soy Bean” Appeal
Since I did a perfectly concise, coherent even, post when the Supreme Court granted cert. in Monsanto v. Bowman back in October, I don’t really have a lot to add. The bloggers and news services have paid a lot of … Continue reading
Posted in Ag Biotechnology
Tagged biotechnology law, Monstanto v Bowman, Supreme Court, Warren Woessner
Leave a comment
Biotech’s PR Problems Continue
Maybe “Fish gotta swim” but the FDA has extended the approval period for transgenic Salmon genetically engineered to reach market weight sooner. No evidence at all has been presented that filets from these fish would present a danger human consumers … Continue reading
Posted in Govt Policy/PTO Policy, Transgenics
Tagged biotechnology, FDA, Supreme Court, Warren Woessner
Leave a comment
ACLU Files Petitioners’ Brief in AMP v. Myriad Appeal
On January 13th, AMP et al. filed a 59 page brief contended that human DNA, including DNA fragments, RNA and cDNA, should not be considered patent-eligible under 35 USC s. 101. There is a lot to read here, much of … Continue reading